Stockreport

Biogen Announces Topline Results from Phase 3 Gene Therapy Study in Choroideremia

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF The Phase 3 STAR study did not meet primary or key secondary endpointsChoroideremia is a rare inherited retinal disease that results in progressive vision loss, ultimate [Read more]